» Articles » PMID: 32991572

Use of the Gout Impact Scale to Evaluate Quality of Life in Chinese Subjects with Gout: A Cross-Sectional Study

Overview
Journal Med Sci Monit
Date 2020 Sep 29
PMID 32991572
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND To use a gout-specific quality of life (QoL) tool, the Gout Impact Scale (GIS), to evaluate characteristics of gout affecting QoL in subjects with gout. MATERIAL AND METHODS In this cross-sectional study, 169 individuals with gout completed the 24-item GIS and a general questionnaire regarding gout characteristics. The reliability and validity of the GIS were verified by Cronbach's a and exploratory factor analysis, respectively. The impact of gout characteristics on the QoL of subjects with gout was assessed by stepwise multiple regression analysis. RESULTS The 169 subjects with gout included 149 (88.2%) men and 20 (11.8%) women, of median age 43 years. The reliability of the GIS was appropriate (0.84-0.90), except for Gout Medication Side Effects (0.69) and Unmet Gout Treatment Need (0.59). Exploratory factor analysis showed that construct validity was acceptable, with a cumulative variance contribution rate of 5 common factors of 70.09% and factor loading >0.5 between each pair of items of the GIS. Univariate analysis showed that male sex was positively correlated with Well-being During Attack (p<0.05), and that source of medical expenses, current cigarette use and drinking were significantly correlated with Unmet Gout Treatment Need (p<0.05 each). A family history of gout, gout flares, and attack frequency were significantly correlated with total GIS, Well-being During Attack, and Gout Concern during Attack (p<0.05 each). Multivariate analysis suggested that history of gouty arthritis, acute attack and attack frequency had a considerable impact on QoL (p<0.05 each). CONCLUSIONS The GIS showed acceptable reliability and validity in identifying associations between poor QoL and gout characteristics.

Citing Articles

Risk factors for loss to follow-up in patients with gout: A Korean prospective cohort study.

Do H, Son C, Choi H, Kim J, Kim M, Shin K PLoS One. 2025; 20(2):e0318564.

PMID: 39919085 PMC: 11805391. DOI: 10.1371/journal.pone.0318564.


High vegetable consumption and regular exercise are associated with better quality of life in patients with gout.

Do H, Choi H, Choi B, Son C, Kim S, Ha Y Korean J Intern Med. 2024; 39(5):845-854.

PMID: 38910514 PMC: 11384246. DOI: 10.3904/kjim.2023.476.


The Relationship Between Psychosocial Behavior and the Quality of Life of Male Gout Patients in Southwest China: A Cross-Sectional Study Based on an Information-Motivation-Behavioral Skills Model.

Wang Y, Guo X, Chen B, Chen H, Chen Y, Ma L Patient Prefer Adherence. 2023; 17:3503-3514.

PMID: 38146501 PMC: 10749546. DOI: 10.2147/PPA.S434875.


Regulatory Role of miRNAs and lncRNAs in Gout.

Shu J, Chen M, Ya C, Yang R, Li F Comput Math Methods Med. 2022; 2022:6513565.

PMID: 35813414 PMC: 9259367. DOI: 10.1155/2022/6513565.

References
1.
Khanna P, Perez-Ruiz F, Maranian P, Khanna D . Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout. Rheumatology (Oxford). 2010; 50(4):740-5. PMC: 3060621. DOI: 10.1093/rheumatology/keq346. View

2.
Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P . EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006; 65(10):1312-24. PMC: 1798308. DOI: 10.1136/ard.2006.055269. View

3.
Scire C, Manara M, Cimmino M, Govoni M, Salaffi F, Punzi L . Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR). Arthritis Res Ther. 2013; 15(5):R101. PMC: 3979095. DOI: 10.1186/ar4281. View

4.
Robinson P, Dalbeth N, Donovan P . The Cost-effectiveness of Biannual Serum Urate (SU) Monitoring after Reaching Target in Gout: A Health Economic Analysis Comparing SU Monitoring. J Rheumatol. 2018; 45(5):697-704. DOI: 10.3899/jrheum.170199. View

5.
Prior J, Mallen C, Chandratre P, Muller S, Richardson J, Roddy E . Gout characteristics associate with depression, but not anxiety, in primary care: Baseline findings from a prospective cohort study. Joint Bone Spine. 2016; 83(5):553-8. DOI: 10.1016/j.jbspin.2015.10.008. View